Cervical Squamous Cell Carcinoma
About
Mappings
NCI Thesaurus: Cervical Squamous Cell Carcinoma (coding:ncit:C4028)
OncoTree: Cervical Squamous Cell Carcinoma (coding:oncotree:CESC)
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) | PD-L1 (CPS) >= 1 | Cervical Squamous Cell Carcinoma | Cisplatin, Paclitaxel, Pembrolizumab | |
| FDA (2) | PD-L1 (CPS) >= 1 | Cervical Squamous Cell Carcinoma | Bevacizumab, Cisplatin, Paclitaxel, Pembrolizumab | |
| FDA (2) | PD-L1 (CPS) >= 1 | Cervical Squamous Cell Carcinoma | Carboplatin, Paclitaxel, Pembrolizumab | |
| FDA (2) | PD-L1 (CPS) >= 1 | Cervical Squamous Cell Carcinoma | Bevacizumab, Carboplatin, Paclitaxel, Pembrolizumab | |
| FDA (2) | PD-L1 (CPS) >= 1 | Cervical Squamous Cell Carcinoma | Pembrolizumab |